EGRX
Eagle Pharmaceuticals Inc
Price:  
2.14 
USD
Volume:  
4,664,101.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX Probability of Bankruptcy

The Probability of Bankruptcy of Eagle Pharmaceuticals Inc (EGRX) is 0.62% . This number represents the probability that EGRX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating EGRX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

EGRX - ESG ratings

ESG ratings are directly linked to the cost of capital and EGRX's ability to raise funding, both of which can significantly affect the probability of Eagle Pharmaceuticals Inc going bankrupt.

ESG Score 18.27
Environment Score 3.21
Social Score 22.35
Governance Score 29.26
Returns
Historical Returns (5 day) 10.39%
Historical Returns (MTD) 19.72%
Historical Returns (YTD) -83.75%
Historical Returns (13 week) -78.21%
Historical Returns (26 week) -78.75%
Historical Returns (52 week) -85.47%
Efficiency
Asset Turnover 0.64
Receiveable Turnover 2.56
Gross Margin 69.86%
Operating Margin 14.02%
Pretax Margin 11.30%
Net Margin 4.70%
Return on Asset (ROA) 3.00
Return on Equity (ROE) 5.04
Return on Investments (ROI) 3.93
Price Metrics
Market Cap (M) 11.04
Enterprise Value (M)
52 Week High 6.81
52 Week Low 0.00
Beta 3.79
Average Volume (10 day) 0.01
Average Volume (3 month) 0.15
Price / Earnings (P/E) 0.91
Price / Sales (P/S) 0.04
Earnings
EPS 0.92
Revenue CAGR (5 year) 5.99%
Risk
Current Ratio 2.16
Quick Ratio 1.52